Antimicrobial activity of Ankaferd Blood StopperA (R) against nosocomial bacterial pathogens


SARIBAŞ Z. , ŞENER B. , HAZNEDAROĞLU İ. C. , Hascelik G. , Kirazli S., GÖKER H.

CENTRAL EUROPEAN JOURNAL OF MEDICINE, cilt.5, ss.198-202, 2010 (SCI İndekslerine Giren Dergi) identifier identifier

  • Cilt numarası: 5 Konu: 2
  • Basım Tarihi: 2010
  • Doi Numarası: 10.2478/s11536-009-0140-4
  • Dergi Adı: CENTRAL EUROPEAN JOURNAL OF MEDICINE
  • Sayfa Sayıları: ss.198-202

Özet

The aim of this study is to investigate the in vitro antimicrobial activity of Ankaferd Blood StopperA (R) against methicillin-resistant Staphylococcus aureus (MRSA), Enterococcus species, Escherichia coli, Pseudomonas species, Acinetobacter species and Klebsiella species of nosocomial origin. Ankaferd inhibited growth in 72.4% to 100% of the bacteria tested, depending on the type of the isolate. As a result, it can be stated that Ankaferd inhibits the in vitro growth of nosocomial bacteria. This is a novel, important finding since severe hospital infections coexist with many hemostatic disorders, and the use of Ankaferd may increase hemostatic potential in such clinical conditions.